How Can New Vaccines be Rolled Out More Effectively? 12/12/2022 Editorial team Whether researchers provide good quality data or not, healthcare systems will continue to function. In this episode of the “Global Health Matters” podcast, Margaret Gyapong, director of the Institute for Health Research at the University of Health and Allied Sciences in Ghana, tells host Garry Aslanyan that this has been a hard lesson that has […] Continue reading -> Exclusive: Global Vaccine Alliance Denies Reports It Has Decided to End Free COVID Vaccines for 37 Middle Income Nations 09/12/2022 Stefan Anderson & Elaine Ruth Fletcher Gavi, the Vaccine Alliance, has pushed back on media reports that its board has decided to end COVID vaccine support for 37 middle-income countries next year – and end altogether the dedicated COVAX vaccine facility, supplying free vaccines to some 92 low- and middle-income countries, in 2024. A high-ranking official at Gavi told Health Policy […] Continue reading -> Investment in Innovation Key to Achieving Sustainable Development Health Goals 09/12/2022 Megha Kaveri The world can achieve the global health goals of the Sustainable Development Agenda 2030 only if it makes focussed investments into health innovation in the coming years. This was a key message from parliamentarians and representatives of the global health agency, UNITAID, at a panel on “Achieving the Global Health Targets Through Equitable Access to […] Continue reading -> Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake […] Continue reading -> South Korea Becomes First Country to Achieve Highest Level in WHO’s Medicine And Vaccine Regulatory Assessment 01/12/2022 Megha Kaveri South Korea became the first country in the world to achieve the highest level, “maturity level 4” (ML4), in regulating medicines and vaccines. The Ministry of Food and Drug Safety (MFDS) in the Republic of Korea is the only national regulatory authority to be recognised by the World Health Organization (WHO) to have advanced oversight […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Bacterial Pathogens Killed 7.7 million in 2019 – But Barely Attract Research Funding 23/11/2022 Megha Kaveri Some 7.7 million people are estimated to have been killed by bacterial pathogens in 2019 according to a study published in The Lancet this week, making this the second leading cause of death globally in2019. Some 33 bacterial pathogens across 11 infectious syndromes were linked to 13.6% of all global deaths in 2019, according to […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Skin to Skin Contact between Mothers and Preterm, Underweight Babies Improve Chances of Survival, says WHO 15/11/2022 Megha Kaveri The World Health Organization (WHO) has strongly recommended that babies born before 37 weeks of gestation (preterm) or with low birth weight should be provided immediate skin to skin contact with a caregiver, which in turn increases their chances of survival. This recommendation by the global health agency is a significant change from the previous […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Exclusive: Global Vaccine Alliance Denies Reports It Has Decided to End Free COVID Vaccines for 37 Middle Income Nations 09/12/2022 Stefan Anderson & Elaine Ruth Fletcher Gavi, the Vaccine Alliance, has pushed back on media reports that its board has decided to end COVID vaccine support for 37 middle-income countries next year – and end altogether the dedicated COVAX vaccine facility, supplying free vaccines to some 92 low- and middle-income countries, in 2024. A high-ranking official at Gavi told Health Policy […] Continue reading -> Investment in Innovation Key to Achieving Sustainable Development Health Goals 09/12/2022 Megha Kaveri The world can achieve the global health goals of the Sustainable Development Agenda 2030 only if it makes focussed investments into health innovation in the coming years. This was a key message from parliamentarians and representatives of the global health agency, UNITAID, at a panel on “Achieving the Global Health Targets Through Equitable Access to […] Continue reading -> Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake […] Continue reading -> South Korea Becomes First Country to Achieve Highest Level in WHO’s Medicine And Vaccine Regulatory Assessment 01/12/2022 Megha Kaveri South Korea became the first country in the world to achieve the highest level, “maturity level 4” (ML4), in regulating medicines and vaccines. The Ministry of Food and Drug Safety (MFDS) in the Republic of Korea is the only national regulatory authority to be recognised by the World Health Organization (WHO) to have advanced oversight […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Bacterial Pathogens Killed 7.7 million in 2019 – But Barely Attract Research Funding 23/11/2022 Megha Kaveri Some 7.7 million people are estimated to have been killed by bacterial pathogens in 2019 according to a study published in The Lancet this week, making this the second leading cause of death globally in2019. Some 33 bacterial pathogens across 11 infectious syndromes were linked to 13.6% of all global deaths in 2019, according to […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Skin to Skin Contact between Mothers and Preterm, Underweight Babies Improve Chances of Survival, says WHO 15/11/2022 Megha Kaveri The World Health Organization (WHO) has strongly recommended that babies born before 37 weeks of gestation (preterm) or with low birth weight should be provided immediate skin to skin contact with a caregiver, which in turn increases their chances of survival. This recommendation by the global health agency is a significant change from the previous […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Investment in Innovation Key to Achieving Sustainable Development Health Goals 09/12/2022 Megha Kaveri The world can achieve the global health goals of the Sustainable Development Agenda 2030 only if it makes focussed investments into health innovation in the coming years. This was a key message from parliamentarians and representatives of the global health agency, UNITAID, at a panel on “Achieving the Global Health Targets Through Equitable Access to […] Continue reading -> Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake […] Continue reading -> South Korea Becomes First Country to Achieve Highest Level in WHO’s Medicine And Vaccine Regulatory Assessment 01/12/2022 Megha Kaveri South Korea became the first country in the world to achieve the highest level, “maturity level 4” (ML4), in regulating medicines and vaccines. The Ministry of Food and Drug Safety (MFDS) in the Republic of Korea is the only national regulatory authority to be recognised by the World Health Organization (WHO) to have advanced oversight […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Bacterial Pathogens Killed 7.7 million in 2019 – But Barely Attract Research Funding 23/11/2022 Megha Kaveri Some 7.7 million people are estimated to have been killed by bacterial pathogens in 2019 according to a study published in The Lancet this week, making this the second leading cause of death globally in2019. Some 33 bacterial pathogens across 11 infectious syndromes were linked to 13.6% of all global deaths in 2019, according to […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Skin to Skin Contact between Mothers and Preterm, Underweight Babies Improve Chances of Survival, says WHO 15/11/2022 Megha Kaveri The World Health Organization (WHO) has strongly recommended that babies born before 37 weeks of gestation (preterm) or with low birth weight should be provided immediate skin to skin contact with a caregiver, which in turn increases their chances of survival. This recommendation by the global health agency is a significant change from the previous […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Homicide Charges for Those Making Harmful Fake Medicine? 07/12/2022 Kerry Cullinan There should be much harsher penalties, including homicide charges, for those who intentionally falsify medicine and include harmful ingredients, according to Kawaldip Sehmi, CEO of the International Alliance of Patients’ Organisations (IAPO). Sehmi was speaking at an event hosted by Fight the Fakes Alliance in Geneva on Wednesday to highlight the global proliferation of fake […] Continue reading -> South Korea Becomes First Country to Achieve Highest Level in WHO’s Medicine And Vaccine Regulatory Assessment 01/12/2022 Megha Kaveri South Korea became the first country in the world to achieve the highest level, “maturity level 4” (ML4), in regulating medicines and vaccines. The Ministry of Food and Drug Safety (MFDS) in the Republic of Korea is the only national regulatory authority to be recognised by the World Health Organization (WHO) to have advanced oversight […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Bacterial Pathogens Killed 7.7 million in 2019 – But Barely Attract Research Funding 23/11/2022 Megha Kaveri Some 7.7 million people are estimated to have been killed by bacterial pathogens in 2019 according to a study published in The Lancet this week, making this the second leading cause of death globally in2019. Some 33 bacterial pathogens across 11 infectious syndromes were linked to 13.6% of all global deaths in 2019, according to […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Skin to Skin Contact between Mothers and Preterm, Underweight Babies Improve Chances of Survival, says WHO 15/11/2022 Megha Kaveri The World Health Organization (WHO) has strongly recommended that babies born before 37 weeks of gestation (preterm) or with low birth weight should be provided immediate skin to skin contact with a caregiver, which in turn increases their chances of survival. This recommendation by the global health agency is a significant change from the previous […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
South Korea Becomes First Country to Achieve Highest Level in WHO’s Medicine And Vaccine Regulatory Assessment 01/12/2022 Megha Kaveri South Korea became the first country in the world to achieve the highest level, “maturity level 4” (ML4), in regulating medicines and vaccines. The Ministry of Food and Drug Safety (MFDS) in the Republic of Korea is the only national regulatory authority to be recognised by the World Health Organization (WHO) to have advanced oversight […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Bacterial Pathogens Killed 7.7 million in 2019 – But Barely Attract Research Funding 23/11/2022 Megha Kaveri Some 7.7 million people are estimated to have been killed by bacterial pathogens in 2019 according to a study published in The Lancet this week, making this the second leading cause of death globally in2019. Some 33 bacterial pathogens across 11 infectious syndromes were linked to 13.6% of all global deaths in 2019, according to […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Skin to Skin Contact between Mothers and Preterm, Underweight Babies Improve Chances of Survival, says WHO 15/11/2022 Megha Kaveri The World Health Organization (WHO) has strongly recommended that babies born before 37 weeks of gestation (preterm) or with low birth weight should be provided immediate skin to skin contact with a caregiver, which in turn increases their chances of survival. This recommendation by the global health agency is a significant change from the previous […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Bacterial Pathogens Killed 7.7 million in 2019 – But Barely Attract Research Funding 23/11/2022 Megha Kaveri Some 7.7 million people are estimated to have been killed by bacterial pathogens in 2019 according to a study published in The Lancet this week, making this the second leading cause of death globally in2019. Some 33 bacterial pathogens across 11 infectious syndromes were linked to 13.6% of all global deaths in 2019, according to […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Skin to Skin Contact between Mothers and Preterm, Underweight Babies Improve Chances of Survival, says WHO 15/11/2022 Megha Kaveri The World Health Organization (WHO) has strongly recommended that babies born before 37 weeks of gestation (preterm) or with low birth weight should be provided immediate skin to skin contact with a caregiver, which in turn increases their chances of survival. This recommendation by the global health agency is a significant change from the previous […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Bacterial Pathogens Killed 7.7 million in 2019 – But Barely Attract Research Funding 23/11/2022 Megha Kaveri Some 7.7 million people are estimated to have been killed by bacterial pathogens in 2019 according to a study published in The Lancet this week, making this the second leading cause of death globally in2019. Some 33 bacterial pathogens across 11 infectious syndromes were linked to 13.6% of all global deaths in 2019, according to […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Skin to Skin Contact between Mothers and Preterm, Underweight Babies Improve Chances of Survival, says WHO 15/11/2022 Megha Kaveri The World Health Organization (WHO) has strongly recommended that babies born before 37 weeks of gestation (preterm) or with low birth weight should be provided immediate skin to skin contact with a caregiver, which in turn increases their chances of survival. This recommendation by the global health agency is a significant change from the previous […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Skin to Skin Contact between Mothers and Preterm, Underweight Babies Improve Chances of Survival, says WHO 15/11/2022 Megha Kaveri The World Health Organization (WHO) has strongly recommended that babies born before 37 weeks of gestation (preterm) or with low birth weight should be provided immediate skin to skin contact with a caregiver, which in turn increases their chances of survival. This recommendation by the global health agency is a significant change from the previous […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Skin to Skin Contact between Mothers and Preterm, Underweight Babies Improve Chances of Survival, says WHO 15/11/2022 Megha Kaveri The World Health Organization (WHO) has strongly recommended that babies born before 37 weeks of gestation (preterm) or with low birth weight should be provided immediate skin to skin contact with a caregiver, which in turn increases their chances of survival. This recommendation by the global health agency is a significant change from the previous […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> Posts navigation Older postsNewer posts